Model Number LH130 |
Device Problem
Device Issue (2379)
|
Patient Problem
No Patient Involvement (2645)
|
Event Date 04/20/2015 |
Event Type
Injury
|
Event Description
|
The user facility reported directly to the fda that while prepping perfusion tubing for a procedure, and not yet hooked up to a patient, the terumo h-130 one-way valve appeared to be faulty and caused a serious injury.The event was discovered by the manufacturer in the (b)(4) maude database review resulting in very limited available information.
|
|
Manufacturer Narrative
|
Terumo has not received the actual device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and more information becomes available.Evaluation in progress.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to the fda in accord with applicable regulations - and as indicated by terumo cardiovascular system.It was determined through information gathered by the user facility and distribution center, that the complaint related to this event was a duplicate of a previous complaint.This event had been previously reported and investigated through mfr # 1124841-2015-00173.The investigation and conclusion results reported in mfr # 1124841-2015-00173 have not changed due to this duplicate complaint.Terumo will be closing the duplicate complaint and all investigation results and conclusions for this report can be found in the original report for this event, in mfr # 1124841-2015-00173.All available information has been placed on file in quality management for appropriate tracking, trending and follow up.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations- and as indicated by terumo cardiovascular system in the initial report submitted to the fda on 06/02/2015.A second follow-up will be submitted upon completion of the investigation and/or submission of new information, thus tcvs references conclusion code.All available information has been placed on file in quality management for appropriate tracking, trending and follow up.
|
|
Event Description
|
A voluntary medwatch report was received from the fda through which terumo was informed that the event required intervention of some kind.Details of this intervention were not provided.
|
|
Search Alerts/Recalls
|